Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1
暂无分享,去创建一个
R. Young | B. Walker | R. Johnson | P. Johnson | A. Aldovini | H. Eisen | T. Tsomides | R. Johnson | R. | R. Young | R. Young
[1] M. Jackson,et al. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Pamer,et al. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. , 1994, Journal of immunology.
[3] H. Eisen,et al. A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Riddell,et al. CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection. , 1993, Current opinion in immunology.
[5] H. Ljunggren,et al. Antigen processing mutant T2 cells present viral antigen restricted through H‐2K , 1993, European journal of immunology.
[6] R. Siliciano,et al. Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells , 1993, Nature.
[7] H. Rammensee,et al. MHC class I-restricted antigen processing--lessons from natural ligands. , 1993, Chemical Immunology.
[8] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant , 1993, The Lancet.
[9] Tsomides Tj. Sample preparation for HPLC by Centricon ultrafiltration. , 1993 .
[10] B. Walker,et al. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. , 1993, Journal of immunology.
[11] A. Fauci,et al. The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.
[12] X. Jin,et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.
[13] H. Eisen,et al. Identification of naturally occurring peptides associated with MHC molecules. , 1993, Chemical immunology.
[14] B. Walker,et al. Cytotoxic T-cell epitopes in HIV/SIV infection. , 1993, AIDS.
[15] A. Hughes,et al. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. , 1992, Journal of immunology.
[16] H. Rammensee,et al. Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. , 1992, International immunology.
[17] C. Griscelli,et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus‐1‐infected mothers , 1992, European journal of immunology.
[18] D. Nixon,et al. Cellular and humoral antigenic epitopes in HIV and SIV. , 1992, Immunology.
[19] H. Eisen,et al. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein , 1992, Cell.
[20] J. Berzofsky,et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. , 1992, The Journal of infectious diseases.
[21] B. Walker,et al. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation , 1992, The Journal of experimental medicine.
[22] B. Walker,et al. An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[24] R. Koup,et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities , 1991, The Journal of experimental medicine.
[25] Peter Walden,et al. Exact prediction of a natural T cell epitope , 1991, European journal of immunology.
[26] A. Meyerhans,et al. In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity , 1991, European journal of immunology.
[27] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[28] M. Schilham,et al. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 , 1991, Nature.
[29] J. Berzofsky,et al. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types. , 1991, The Journal of clinical investigation.
[30] B. Walker,et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. , 1991, Journal of immunology.
[31] P. Cresswell,et al. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I- restricted cell-mediated lysis , 1991, The Journal of experimental medicine.
[32] H. Rammensee,et al. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.
[33] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[34] J. Levy,et al. Rapid CD8+ Cell Anti-HIV Activity Correlates with the Clinical State of the Infected Individual , 2003 .
[35] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[36] S. Nathenson,et al. Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.
[37] Rolf M. Zinkernagel,et al. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.
[38] P. Cresswell,et al. Presentation of viral antigen controlled by a gene in the major histocompatibility complex , 1990, Nature.
[39] M. Bevan,et al. Defective presentation of endogenous antigen by a cell line expressing class I molecules. , 1990, Science.
[40] J. Berzofsky,et al. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. Watkins,et al. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. , 1989, Disease markers.
[42] M. Feinberg,et al. Transfection of Molecularly Cloned HIV Genomes , 1990 .
[43] I. Wilson,et al. Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.
[44] J. Yewdell,et al. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. , 1990, Current topics in microbiology and immunology.
[45] M. Feinberg,et al. HIV revealed: toward a natural history of the infection. , 1989, The New England journal of medicine.
[46] R. Young,et al. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[47] B. Guy,et al. An antigenic peptide of the HIV‐1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA‐B , 1989, European journal of immunology.
[48] L. Sherman,et al. Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response , 1989, The Journal of experimental medicine.
[49] B. Guy,et al. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins , 1989, Journal of virology.
[50] B. Autran,et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. , 1989, Journal of immunology.
[51] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[52] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[53] P. Earl,et al. Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[54] B. Walker,et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.
[55] H. Varmus,et al. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression , 1988, Nature.
[56] B. Autran,et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.
[57] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[58] J. Lifson,et al. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. , 1986, Science.
[59] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[60] R. Gallo,et al. Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[61] Amanda G. Fisher,et al. A molecular clone of HTLV-III with biological activity , 1985, Nature.